Provided by Tiger Trade Technology Pte. Ltd.

Capital Research Global Investors

2,910.58
+31.521.09%
Number of Gainers:62
Number of Losers:33
Number of Flat:- -
PE:- -
High:2,924.13
Open:2,879.17
Low:2,879.17
Close:2,879.06
Volume:634.62M
Turnover:132.66B
Market Cap:33.29T
Float Cap:31.66T

Loading ...

KTX Tactical DR Picks - September 9, 2026 (Eng.)

Smartkarma
·
Sep 09

Adobe's Freemium Strategy in Focus Ahead of F3Q Print in Reset Year

Dow Jones
·
Sep 09

Asian chip stocks rise, crude climbs towards US$100

Toby Alder / Bloomberg
·
Sep 09

Top Midday Decliners

MT Newswires Live
·
Sep 09

Shopify Price Target Raised to $180.00/Share from $172.00 by Piper Sandler

Dow Jones
·
Sep 09

Alphabet's Google to Get Environmental Certificates From Texas Electric Truck Project

MT Newswires Live
·
Sep 09

Italian Sea Group Announces Shareholder Meeting

Reuters
·
Sep 09

Autodesk Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since March 2025

Dow Jones
·
Sep 09

Hoist Finance Lifts Profitability Targets and Portfolio Ambitions to 2030

TIPRANKS
·
Sep 09

Cboe data shows mixed options sentiment in Nike with shares down 0.69%

TIPRANKS
·
Sep 09

Chip Stocks Rally, Citi Issues Bullish Forecast

Reuters
·
Sep 09

Stryker Falls After Warning Manufacturing Challenges Will Linger Through Second Half

Reuters
·
Sep 09

Google says helping put 25 new electric semi trucks on road in Texas

TIPRANKS
·
Sep 09

Gilead Sciences Inc Stock (GILD) Moved Down by 3.26% on Sep 8: Drivers Behind the Movement

TradingKey
·
Sep 09

AI Daily: Qualcomm strikes major AI chip deal with Amazon

TIPRANKS
·
Sep 09

Groupe JAJ Publishes 2025-2026 Annual Report

Reuters
·
Sep 09

How Apple Shares Typically Perform Following Major iPhone Launch Events

Deep News
·
Sep 09

Amgen's Olpasiran May Still Show Heart-Risk Reduction Despite Novartis Miss, UBS Says

MT Newswires Live
·
Sep 09

Microsoft Stock (NASDAQ:MSFT) Dips as More News Organization Lawsuits Hit

TIPRANKS
·
Sep 09

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

THOMSON REUTERS
·
Sep 09